ARCHIVES

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Plans 3 Percent Across-The-Board Cut To Pool Funds For High Priorities In FY08.

September 21, 2007

Bioethics Commission Report Calls For funding To Derive Stem Cells

September 17, 1999

McCormick President-Elect of AACR; Garber To Start Term As President

March 25, 2011

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989

Report on Carcinogens: Advisors Recommend Tobacco, UV Light, Tamoxifen, For Report

November 7, 1997

NIH Faces Cuts Under House, Senate, Administration Plans

May 19, 1995